標(biāo)題: Titlebook: Chronic Viral Hepatitis; Diagnosis and Therap Raymond S. Koff,George Y. Wu Book 20021st edition Springer Science+Business Media New York 20 [打印本頁(yè)] 作者: 哄笑 時(shí)間: 2025-3-21 18:49
書(shū)目名稱Chronic Viral Hepatitis影響因子(影響力)
作者: 和平主義 時(shí)間: 2025-3-21 22:51
Book 20021st editions, supporting patients during therapy, alternative treatments, the use of drugs in chronic viral hepatitis, liver transplantation, and pregnancy in chronic viral hepatitis. Attention is also given to the treatment of patients with concomitant autoimmune disorders, the management of HIV co-infection, and the management of HBV/HCV co-infection.作者: Lineage 時(shí)間: 2025-3-22 02:24
Refractive index of tributyl phosphate,a .. The estimated worldwide prevalence of chronic HCV infection is over 170 million ., and 2.7–3.9 million are infected in the United States .. Cirrhosis caused by HCV infection is currently the leading indication for liver transplantation in the United States ..作者: appall 時(shí)間: 2025-3-22 07:16 作者: airborne 時(shí)間: 2025-3-22 09:01 作者: 表臉 時(shí)間: 2025-3-22 16:54
Drugs and Chronic Viral Hepatitis,such as site-directed inhibitors of enzymes in host human beings, or in infectious agents. Other drugs are targeted at specific receptors such as the histamine type- 1 and -2 receptors, the several types of serotonin receptors, and so on.作者: 表臉 時(shí)間: 2025-3-22 19:55 作者: POLYP 時(shí)間: 2025-3-22 22:52
Refractive index of tetrachloromethane,ghts into molecular virology and pathogenesis, a wide array of diagnostic assays, a safe and effective vaccine, and the introduction of effective treatment strategies designed to reduce the rate of complications.作者: ETHER 時(shí)間: 2025-3-23 01:28
Refractive index of carbon disulfide,egarding the use of this agent in this important patient group is scant. Anecdotal reports and a review of the available literature, however, provide valuable clinical information, and shed light on this intriguing, but poorly documented subject.作者: TEN 時(shí)間: 2025-3-23 08:42
Molecular Virology of Hepatitis B and C, as to permit a more complete understanding of the molecular basis for viral replication, and the concomitant induction or evasion of the host antiviral immune response. Some of the important molecular biological properties of these viruses, as well as how they are reflected in the clinical manifestations of viral infection, are presented below.作者: 滑稽 時(shí)間: 2025-3-23 12:15 作者: Brocas-Area 時(shí)間: 2025-3-23 16:48 作者: 藐視 時(shí)間: 2025-3-23 19:59
2197-7399 viral hepatitis, liver transplantation, and pregnancy in chronic viral hepatitis. Attention is also given to the treatment of patients with concomitant autoimmune disorders, the management of HIV co-infection, and the management of HBV/HCV co-infection.978-1-59259-104-6Series ISSN 2197-7399 Series E-ISSN 2197-7704 作者: ERUPT 時(shí)間: 2025-3-24 00:06
Refractive index of methanol-d4,antibody (anti-HBe), and normalization in alanine aminotransferase (ALT) levels. Currently, two therapeutic agents have been approved by the FDA for the treatment of chronic hepatitis B. Many new antiviral and immunomodulatory therapy are being evaluated, some of them with very promising results.作者: Cleave 時(shí)間: 2025-3-24 03:05
Refractive index of chlorodifluoromethane, therapy will help the clinician in educating the patient and family about the optimal strategies for successful therapy of CHC. Although this chapter focuses predominantly on IFN-based therapy, it also briefly discusses some of the newer treatments for hepatitis C virus (HCV), including pegylated IFNs.作者: 相容 時(shí)間: 2025-3-24 09:49 作者: 碎片 時(shí)間: 2025-3-24 13:12 作者: 性滿足 時(shí)間: 2025-3-24 15:33
2197-7399 es recommendations and indications for requesting GI subspecLeading scientists, clinicians, and clinical investigators comprehensively review the epidemiology, molecular virology, diagnosis, treatment, and prevention of chronic hepatitis caused by the B and C viruses. The discussion of patient manag作者: 招人嫉妒 時(shí)間: 2025-3-24 20:56
Refractive index of tribromomethane,lso been reported. Injection drug use has been associated with the highest risk of HBV and HCV co-infection, compared to other risk groups .. Because of their common mode of transmission, dual infection with HBV and HCV occurs in at-risk patients.作者: 疲憊的老馬 時(shí)間: 2025-3-25 01:22 作者: jaunty 時(shí)間: 2025-3-25 05:15 作者: 偽證 時(shí)間: 2025-3-25 08:56 作者: giggle 時(shí)間: 2025-3-25 11:38
Chronic Viral Hepatitis978-1-59259-104-6Series ISSN 2197-7399 Series E-ISSN 2197-7704 作者: Veneer 時(shí)間: 2025-3-25 17:18 作者: MEAN 時(shí)間: 2025-3-26 00:03 作者: neurologist 時(shí)間: 2025-3-26 03:38
https://doi.org/10.1007/978-1-59259-104-6HIV; Hepatitis C; autoimmune disease; autoimmune diseases; hepatitis; hepatitis B; immunology; infection; li作者: 顯而易見(jiàn) 時(shí)間: 2025-3-26 04:55
Springer Science+Business Media New York 2002作者: 抑制 時(shí)間: 2025-3-26 08:33 作者: Synthesize 時(shí)間: 2025-3-26 13:49 作者: 盟軍 時(shí)間: 2025-3-26 18:36 作者: 袋鼠 時(shí)間: 2025-3-26 22:49 作者: 百科全書(shū) 時(shí)間: 2025-3-27 04:46 作者: GORGE 時(shí)間: 2025-3-27 08:46
Refractive index of carbon disulfide,y patients with hepatitis C escape detection, and current, widely used treatments may affect outcome. Seeff . proposed that the most accurate study to evaluate the natural history of hepatitis C should have five basic components. First, the date of onset of acute hepatitis C should be documented to 作者: 委屈 時(shí)間: 2025-3-27 13:03 作者: 關(guān)心 時(shí)間: 2025-3-27 14:32 作者: 極大的痛苦 時(shí)間: 2025-3-27 18:23 作者: 頭盔 時(shí)間: 2025-3-27 22:50
Refractive index of tributyl phosphate,ubclinical, yet there is a high rate of chronicity after infection. As many as 55–85% of individuals who contract HCV infection will develop chronic infection and hepatitis. Of these, at least 20% will progress to cirrhosis after a 10–30 yr period, and are at risk to develop hepatocelluplar carcinom作者: Orthodontics 時(shí)間: 2025-3-28 04:57
Refractive index of carbon disulfide,s associated with hepatitis C . and, to a lesser extent, hepatitis B .; many of these conditions are mediated through autoimmune mechanisms. Shortly after the release of interferon α-2b (IFN-α2b) for the treatment of these viral infections came reports of autoimmune disorders that were either caused作者: asthma 時(shí)間: 2025-3-28 08:10
Refractive index of tetrachloromethane,patient with chronic viral hepatitis involves taking care of the entire patient, anticipating the needs and potential problems for each patient, and educating the patient regarding their disease and its management. Developing the therapeutic plan and initiating treatment for the patient with chronic作者: lambaste 時(shí)間: 2025-3-28 13:11 作者: 取回 時(shí)間: 2025-3-28 17:26
Refractive index of chlorodifluoromethane,the past decade, the proportion of Americans who report using alternative or complementary therapies has grown from 34 to 42%. During that interval, the projected number of total visits to alternative practitioners increased by 47%, from 427 million visits/yr in 1991 to 629 million visits/yr in 1997作者: Reclaim 時(shí)間: 2025-3-28 20:26
Refractive index of trichloromethane,een fascinated with exogenous chemicals and xenobiotics that affect the mind and body. However, advances in therapeutics have been truly remarkable within the past one or two generations. Increasingly, new drugs are being developed, based on biochemical and structural knowledge of specific targets, 作者: SEVER 時(shí)間: 2025-3-29 01:14
Refractive index of tetrachloromethane,storically, the first liver transplantations, for decompensated cirrhosis caused by chronic viral hepatitis, were performed in the 1970s, in patients with chronic hepatitis B virus (HBV) infection. According to data from the United Network of Organ Sharing (UNOS), of the more than 4000 liver transpl作者: Paraplegia 時(shí)間: 2025-3-29 05:51
https://doi.org/10.1007/978-3-540-75291-2a previously normal gestation, or as pregnancy occurring in a woman with chronic hepatitis. In either situation, special concerns for both mother and child must be considered. In addition, the liver diseases unique to pregnancy can present in the guise of viral hepatitis, providing problems in diffe作者: Mammal 時(shí)間: 2025-3-29 07:34 作者: Flat-Feet 時(shí)間: 2025-3-29 12:24 作者: 微枝末節(jié) 時(shí)間: 2025-3-29 18:35 作者: 施舍 時(shí)間: 2025-3-29 23:31 作者: harmony 時(shí)間: 2025-3-30 00:11
Epidemiology of Hepatitis B and Hepatitis C,dborne routes, such as transfusions or injection drug use. Acute infections often are asymptomatic, but can result in persistent viremia and chronic liver injury. Finally, chronic infection with either virus may cause minimal symptoms for decades, but ultimately can progress to cirrhosis and hepatoc作者: Cacophonous 時(shí)間: 2025-3-30 06:13 作者: PHONE 時(shí)間: 2025-3-30 08:12 作者: offense 時(shí)間: 2025-3-30 14:45
Hepatitis C and HIV Co-Infection,eaths among people with acquired immune deficiency syndrome (AIDS) declined for the first time in 1996, after the institution of this therapeutic approach. As the life expectancy of HIV-infected patients increases, greater attention will need to be focused on the recognition and management of potent作者: micturition 時(shí)間: 2025-3-30 20:24 作者: locus-ceruleus 時(shí)間: 2025-3-30 21:58 作者: 橡子 時(shí)間: 2025-3-31 01:13
Treatment of Chronic Hepatitis C Infection,ubclinical, yet there is a high rate of chronicity after infection. As many as 55–85% of individuals who contract HCV infection will develop chronic infection and hepatitis. Of these, at least 20% will progress to cirrhosis after a 10–30 yr period, and are at risk to develop hepatocelluplar carcinom作者: 調(diào)整 時(shí)間: 2025-3-31 06:49
Treatment of Chronic Viral Hepatitis in Patients with Autoimmune Diseases,s associated with hepatitis C . and, to a lesser extent, hepatitis B .; many of these conditions are mediated through autoimmune mechanisms. Shortly after the release of interferon α-2b (IFN-α2b) for the treatment of these viral infections came reports of autoimmune disorders that were either caused作者: ORBIT 時(shí)間: 2025-3-31 11:07
Developing Therapeutic Plans for Patients with Chronic Hepatitis B or C,patient with chronic viral hepatitis involves taking care of the entire patient, anticipating the needs and potential problems for each patient, and educating the patient regarding their disease and its management. Developing the therapeutic plan and initiating treatment for the patient with chronic作者: 踉蹌 時(shí)間: 2025-3-31 16:42
Supporting the Patient with Chronic Hepatitis During Treatment,ific problem with therapy, but in addition the therapy itself is complex, and is associated with a multitude of side effects. This chapter examines strategies for the management of side effects in patients treated with both interferon (IFN) and IFN—ribavirin combination therapy. In the clinical tria作者: 天真 時(shí)間: 2025-3-31 18:43
Complementary and Alternative Treatment of Liver Disease,the past decade, the proportion of Americans who report using alternative or complementary therapies has grown from 34 to 42%. During that interval, the projected number of total visits to alternative practitioners increased by 47%, from 427 million visits/yr in 1991 to 629 million visits/yr in 1997作者: 獨(dú)行者 時(shí)間: 2025-4-1 00:18
